These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 58180)

  • 1. Dopamine and inhibition of prolactin and growth-hormone secretion.
    Massara F; Camanni F; Belforte L; Molinatti GM
    Lancet; 1976 Apr; 1(7965):913. PubMed ID: 58180
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Dopamine and inhibition of prolactin and growth-hormone secretion.
    Thorner MO; Wass JA; Rees LH; Besser GM; Dyer RG
    Lancet; 1976 Mar; 1(7959):588. PubMed ID: 55861
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Dopamine-induced inhibition of prolactin and growth hormone secretion in acromegaly.
    Massara F; Camanni F; Belfonte L; Molinatti GM
    Lancet; 1976 Feb; 1(7957):485. PubMed ID: 55749
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dopamine on plasma growth hormone and prolactin concentrations under anaesthesia.
    Mikawa K; Kusunoki M; Obara H; Iwai S
    J Int Med Res; 1988; 16(6):403-12. PubMed ID: 3234595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dopamine infusion on pituitary hormone secretion in humans.
    Leblanc H; Lachelin GC; Abu-Fadil S; Yen SS
    J Clin Endocrinol Metab; 1976 Sep; 43(3):668-74. PubMed ID: 956350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormones, feeding and temperature in sheep following cerebroventricular injections of neurotransmitters and carbachol.
    Driver PM; Forbes JM; Scanes CG
    J Physiol; 1979 May; 290(2):399-411. PubMed ID: 469778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine inhibits growth hormone and prolactin secretion in the human newborn.
    De Zegher F; Van Den Berghe G; Devlieger H; Eggermont E; Veldhuis JD
    Pediatr Res; 1993 Nov; 34(5):642-5. PubMed ID: 8284103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD; Lantigua R; Lee LA
    J Clin Endocrinol Metab; 1979 Sep; 49(3):326-30. PubMed ID: 468965
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothalamic catecholamine effects on plasma levels of prolactin and growth hormone in sheep.
    Davis SL; Borger ML
    Endocrinology; 1973 Jan; 92(1):303-9. PubMed ID: 4681932
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of carbidopa on prolactin, growth hormone and cortisol secretion in man.
    Brown GM; Garfinkel PE; Warsh JJ; Stancer HC
    J Clin Endocrinol Metab; 1976 Jul; 43(1):236-9. PubMed ID: 947942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man.
    Vance ML; Kaiser DL; Frohman LA; Rivier J; Vale WW; Thorner MO
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1136-41. PubMed ID: 3553220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
    Cronin MJ; Thorner MO
    J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile growth hormone and prolactin: effects of (+) butaclamol, a dopamine receptor blocking agent.
    Willoughby JO; Brazeau P; Martin JB
    Endocrinology; 1977 Oct; 101(4):1298-303. PubMed ID: 908278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of infused dopamine on free fatty acids in normal females.
    McLellan AR; Shenkin A; Beastall GH; Borland W; Connell JM; Davies DL
    Horm Metab Res; 1989 Mar; 21(3):158-60. PubMed ID: 2744722
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation by dopamine and estradiol of the central effects of angiotensin II on anterior pituitary hormone release.
    Steele MK; McCann SM; Negro-Vilar A
    Endocrinology; 1982 Sep; 111(3):722-9. PubMed ID: 7106048
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurotransmitter control of growth hormone, thyrotropin and prolactin secretion.
    Muller EE; Genazzani AR; Cocchi D; Casanueva F; Camanni F; Massara F; Molinatti GM
    J Endocrinol Invest; 1980; 3(3):331-3. PubMed ID: 6107316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.